Vanguard Group’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.98M | Buy |
666,805
+199,386
| +43% | +$1.49M | ﹤0.01% | 3221 |
|
|
2025
Q1 | $4.57M | Buy |
467,419
+142,122
| +44% | +$1.39M | ﹤0.01% | 3212 |
|
|
2024
Q4 | $1.76M | Buy |
325,297
+24,159
| +8% | +$131K | ﹤0.01% | 3605 |
|
|
2024
Q3 | $1.89M | Buy |
301,138
+50,000
| +20% | +$315K | ﹤0.01% | 3573 |
|
|
2024
Q2 | $1.59M | Sell |
251,138
-47,662
| -16% | -$302K | ﹤0.01% | 3635 |
|
|
2024
Q1 | $2.45M | Buy |
298,800
+4,517
| +2% | +$37K | ﹤0.01% | 3525 |
|
|
2023
Q4 | $2.45M | Buy |
294,283
+3,149
| +1% | +$26.3K | ﹤0.01% | 3532 |
|
|
2023
Q3 | $3.75M | Buy |
291,134
+25,196
| +9% | +$325K | ﹤0.01% | 3363 |
|
|
2023
Q2 | $4.25M | Buy |
265,938
+64,505
| +32% | +$1.03M | ﹤0.01% | 3383 |
|
|
2023
Q1 | $2.64M | Buy |
201,433
+5,604
| +3% | +$73.5K | ﹤0.01% | 3576 |
|
|
2022
Q4 | $1.47M | Buy |
195,829
+168,768
| +624% | +$1.27M | ﹤0.01% | 3781 |
|
|
2022
Q3 | $192K | Buy |
27,061
+3,804
| +16% | +$27K | ﹤0.01% | 4426 |
|
|
2022
Q2 | $261K | Buy |
+23,257
| New | +$261K | ﹤0.01% | 4431 |
|